Dissemination and evaluation of the 3E initiative recommendations for use of methotrexate in rheumatic disorders: results of a study among 2233 rheumatologists

Gossec, L; Bijlsma, JWJ; Bombardier, C; Canhao, H; Devlin, J; Edwards, CJ; Hamuryudan, V; Kvien, TK; Leeb, BF; Martin-Mola, EM; Mielants, H; Muller-Ladner, U; Ostergaard, M; Pereira, IA; Ramos-Remus, C; Zochling, J; Dougados, M

Dissemination and evaluation of the 3E initiative recommendations for use of methotrexate in rheumatic disorders: results of a study among 2233 rheumatologists

journal contribution

posted on 2023-05-17, 03:23 authored by Gossec, L, Bijlsma, JWJ, Bombardier, C, Canhao, H, Devlin, J, Edwards, CJ, Hamuryudan, V, Kvien, TK, Leeb, BF, Martin-Mola, EM, Mielants, H, Muller-Ladner, U, Ostergaard, M, Pereira, IA, Ramos-Remus, C, Zochling, J, Dougados, M

Ten recommendations for the use of methotrexate were recently developed, based on published data and expert opinion in the 3E initiative.

History

Related Materials

1.
DOI - Is supplement to Dissemination and evaluation of the 3E initiative recommendations for use of methotrexate in rheumatic disorders: results of a study among 2233 rheumatologists

Publication title

Annals of The Rheumatic Diseases: The Eular Journal

Volume

70

Pagination

388-389

ISSN

0003-4967

Department/School

Menzies Institute for Medical Research

Publisher

B M J Publishing Group

Place of publication

British Med Assoc House, Tavistock Square, London, England, Wc1H 9Jr

Rights statement

Socio-economic Objectives

Clinical health not elsewhere classified

Repository Status

Restricted

Usage metrics

Dissemination and evaluation of the 3E initiative recommendations for use of methotrexate in rheumatic disorders: results of a study among 2233 rheumatologists

History

Related Materials

Publication title

Volume

Pagination

ISSN

Department/School

Publisher

Place of publication

Rights statement

Socio-economic Objectives

Repository Status

Usage metrics

Categories

Keywords

Licence

Exports